
September 2013 Oncology


Oral antineoplastics have advantages, but patient adherence is a concern.

Gilotrif (afatinib) is FDA approved for treating certain non-small cell lung cancers.

Why are computerized drug-drug interaction alerts usually ignored?




Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.

The nutritional supplements glucosamine and chondroitin have demonstrated some potential for reducing pain associated with osteoarthritis




Federal rules are very specific.
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5